When "Watchful Waiting" Is OK for Prostate Cancer

March 2005
Tufts University Health & Nutrition Letter;Mar2005, Vol. 23 Issue 1, p3
Reports on the potential of "watchful waiting approach" to prostate cancer treatment according to a study conducted by the Erasmus Medical Center in Rotterdam, New York, published in the "Journal of Urology." Reason some men diagnosed with the disease opt for the approach.


Related Articles

  • Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Taira, A. V.; Merrick, G. S.; Galbreath, R. W.; Andreini, H.; Taubenslag, W.; Curtis, R.; Butler, W. M.; Adamovich, E.; Wallner, K. E. // Prostate Cancer & Prostatic Diseases;2010, Vol. 13 Issue 1, p71 

    Transrectal ultrasound (TRUS) biopsy can miss 20–30% of clinically significant cancers. We evaluate an alternative approach—transperineal template-guided mapping biopsy (TTMB) in the initial and repeat biopsy setting. From January 2005 through September 2008, 373 consecutive men...

  • Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate: A Randomized Controlled Trial. Zietman, Anthony L.; DeSilvio, Michelle L.; Slater, Jerry D.; Rossi, Carl J.; Miller, Daniel W.; Adams, Judith A.; Shipley, William U. // JAMA: Journal of the American Medical Association;9/14/2005, Vol. 294 Issue 10, p1233 

    Context Clinically localized prostate cancer is very prevalent among US men, but recurrence after treatment with conventional radiation therapy is common. Objective To evaluate the hypothesis that increasing the radiation dose delivered to men with clinically localized prostate cancer improves...

  • We Pray for the Cure. RICHARDSON, WALTER T. // South Florida Times;9/3/2015, Vol. 25 Issue 36, p4B 

    The article discusses detection, elimination and cure of prostate cancer in its early stages for men over 40 years of age through regular examinations, participation in online or small group discussions about developments in cancer treatments and praying for the cure.

  • Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Montironi, Rodolfo; Hammond, Elizabeth; Lin, Daniel; Gore, John; Srigley, John; Samaratunga, Hema; Egevad, Lars; Rubin, Mark; Nacey, John; Klotz, Laurence; Sandler, Howard; Zietman, Anthony; Holden, Stuart; Humphrey, Peter; Evans, Andrew; Delahunt, Brett; McKenney, Jesse; Berney, Daniel; Wheeler, Thomas; Chinnaiyan, Arul // Virchows Archiv;Dec2014, Vol. 465 Issue 6, p623 

    Active surveillance (AS) is an important management option for men with low-risk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts matures. Vital to this process is...

  • Are We Doing Enough to Promote Bone Health in Men with Prostate Cancer? Boyd, Lee Ann // Urologic Nursing;Dec2008, Vol. 28 Issue 6, p412 

    The author reflects on efforts to promote bone health in men with prostate cancer. She relates that osteoporosis in men has been overlooked or underdiagnosed, and that both the physician and patient must play an active role in preventing osteoporosis. According to the author, healthcare...

  • New Therapies for Prostate Cancer Based on the Biology of Androgen Receptor Coregulators. Zhang, Yuexing; Hamburger, Anne W. // Current Cancer Therapy Reviews;2010, Vol. 6 Issue 3, p185 

    Prostate cancer is currently the most prevalent cancer among men in the United States and ranks second to lung cancer in terms of annual mortality. The androgen receptor (AR) is central to the initiation and growth of prostate cancer and to the therapeutic response to hormones. Although it has...

  • Prostate cancer: Controversy over testing and treatment.  // Westchester County Business Journal;10/18/2004, Vol. 43 Issue 42, pS6 

    Focuses on the debate over the benefits and limitations associated with prostate cancer testing and treatment. Total number of men in the United States that the American Cancer Society (ACS) predicts will be diagnosed with prostate cancer in 2004; Society's recommendations concerning prostate...

  • Pilot Evaluation of Paroxetine for Treating Hot Flashes in Men. Loprinzi, Charles L.; Barton, Debra L.; Carpenter, Lisa A.; Sloan, Jeff A.; Novontny, Paul J.; Gettman, Matthew T.; Christensen, Bradley J. // Mayo Clinic Proceedings;Oct2004, Vol. 79 Issue 10, p1247 

    OBJECTIVE: To provide prospective information on the potential utility of paroxetine for treating hot flashes in men receiving androgen ablation therapy for prostate cancer. PATIENTS AND METHODS: Men with symptomatic androgen ablation therapy-related hot flashes were entered into this clinical...

  • BETA-SITOSTEROL. Strum, Stephen B.; Faloon, William // Life Extension;Jun2005, Vol. 11 Issue 6, p26 

    Provides information on beta-sitosterol, a plant extract that can improve urinary symptoms related to prostate enlargement in men. Utilization of beta-sitosterol in several European prostate drugs; Remarkable effects of beta-sitosterol; Ability of beta-sitosterol to inhibit cancer cell growth.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics